Target intelligence / Profile preview

Scavenger receptors on antigen-presenting cells (SRs) (SRs)

Target
SRs
Molecular classification
Receptor, Glycoprotein, Transmembrane protein
01

Overview

Scavenger receptors on antigen-presenting cells (APCs) are a heterogeneous group of cell-surface glycoproteins that mediate the binding and uptake of various ligands, including modified lipids and pathogens [1, 2]. This specific grouping, often categorized in biological databases as 'Other scavenger receptors,' includes molecules such as CD163, Stabilin-1 (STAB1), and Stabilin-2 (STAB2) [1]. These receptors are essential for maintaining tissue homeostasis by facilitating efferocytosis, the process of clearing apoptotic cells and cellular debris [3]. Beyond clearance, they function as pattern recognition receptors that trigger or modulate signaling pathways involved in the innate immune response [2, 3]. In clinical contexts, these receptors are significant in atherosclerosis, where they contribute to lipid accumulation, and in oncology, where they are markers of immunosuppressive macrophage phenotypes [4, 5]. CD163, for example, is a well-known scavenger for hemoglobin-haptoglobin complexes and serves as a diagnostic marker for macrophage activation [4]. Stabilins are involved in the clearance of hyaluronan and are implicated in liver fibrosis and cancer metastasis [5]. Therapeutic targeting of these receptors aims to reprogram macrophage activity or block the uptake of harmful substances to treat inflammatory and metabolic disorders [1, 4].

Other names
Other scavenger receptors on antigen-presenting cellsScavenger receptor familyCD163Stabilin-1 (STAB1)Stabilin-2 (STAB2)Scavenger receptor with C-type lectin (SRCL)SSC5D
02

Mechanism of action

Binding and internalization of polyanionic ligands, apoptotic cells, and hemoglobin-haptoglobin complexes to facilitate clearance and modulate immune signaling.

03

Biological functions

Immune responsePhagocytosisEndocytosisAntigen presentationTissue homeostasisEfferocytosis
04

Disease associations

InflammationInfectionCancerAtherosclerosisLiver fibrosis
05

Safety considerations

Impaired clearance of apoptotic cellsPotential for systemic inflammationOff-target effects on lipid and hyaluronan metabolism
06

Interacting drugs

Dexamethasone

3 more in the full profile.

07

Biomarkers

Soluble CD163 (sCD163)Stabilin-1 expressionCD163+ macrophage density

Beyond the preview

Go deeper on Scavenger receptors on antigen-presenting cells (SRs) (SRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scavenger receptors on antigen-presenting cells (SRs) (SRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call